A detailed history of Adar1 Capital Management, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 7,318 shares of EQ stock, worth $4,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,318
Previous 140,775 94.8%
Holding current value
$4,463
Previous $97.6 Million 93.76%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.64 - $1.13 $85,412 - $150,806
-133,457 Reduced 94.8%
7,318 $6.09 Million
Q2 2024

Aug 13, 2024

SELL
$0.66 - $2.33 $38,280 - $135,140
-58,000 Reduced 29.18%
140,775 $97.6 Million
Q1 2024

May 15, 2024

BUY
$0.73 - $3.0 $140,360 - $576,825
192,275 Added 2958.08%
198,775 $459 Million
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.74 $3,120 - $4,810
6,500 New
6,500 $4.7 Million

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $21M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.